How is the tick vaccine administered to adults?

How is the tick vaccine administered to adults? - briefly

The «tick vaccine» is given by subcutaneous injection, usually in two doses four weeks apart followed by a booster after twelve months. Administration is performed by a qualified healthcare professional in a clinical setting.

How is the tick vaccine administered to adults? - in detail

The tick vaccine for adults is given as a sterile, single‑dose injection administered intramuscularly, typically in the deltoid muscle. Prior to injection, the vial must be stored at 2 °C–8 °C, protected from light, and allowed to reach room temperature for 15–30 minutes. The vial is inspected for particulate matter or discoloration; any anomaly requires discarding the product.

Preparation steps:

  • Remove the cap using aseptic technique.
  • Swirl the vial gently; do not shake.
  • Withdraw the required volume (0.5 mL) with a sterile syringe and needle (22‑25 G).
  • Expel any air bubbles, then attach the needle securely.

Administration procedure:

  1. Identify the deltoid region, clean the skin with an alcohol swab, and allow it to dry.
  2. Insert the needle at a 90° angle, penetrating the muscle tissue.
  3. Depress the plunger slowly to deliver the full dose.
  4. Withdraw the needle, apply gentle pressure with a sterile gauze, and cover with a small adhesive bandage.

Post‑injection monitoring includes a 15‑minute observation period to detect immediate adverse reactions such as local erythema, swelling, or systemic signs (e.g., fever, anaphylaxis). Patients should be advised to report any persistent pain, redness extending beyond the injection site, or neurological symptoms within 48 hours.

Contraindications encompass known hypersensitivity to any vaccine component, severe immunodeficiency, and active febrile illness at the time of vaccination. Pregnant or lactating individuals should consult a healthcare professional before receiving the vaccine.

Recommended schedule for adults at risk of tick‑borne diseases involves a primary series of two doses, spaced four weeks apart, followed by an annual booster to maintain immunity. Documentation of each administration, including batch number and expiration date, must be recorded in the patient’s immunization record.